F11
Reactivité: Humain
WB, EIA
Hôte: Lapin
Polyclonal
unconjugated
Indications d'application
Inhibitory in clotting assays. Useful for purification of Factor XI. Western blot (non-reduced samples only, band size 160 kD). RIA. ELISA. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Restrictions
For Research Use only
Concentration
12.4 mg/mL (OD280 nm, E1% = 14)
Buffer
50 % (vol/vol) glycerol/water) without preservatives
Agent conservateur
Without preservative
Conseil sur la manipulation
This product is photosensitive and should be protected from light
Factor X is activated by the cleavage of the activation peptide by factor IXa (in the intrisic pathway), or by factor VIIa (in the extrinsic pathway). The activated factor then converts prothrombin to thrombin in the presence of factor Va, Ca+2, and phospholipid during blood clotting. Mutations of this gene result in factor X deficiency, a haemorrhagic condition of variable severity.Synonyms: FX1, PTA, Plasma thromboplastin antecedent